Common diabetes drug may serve as novel Afib treatment
Oct 13, 2022
If approved, it would be the first new drug identified to treat this disease of the heart in a decade, according to Cleveland Clinic researchers.
Clinical briefs for Friday, Aug. 19
Aug 19, 2022
Senior living operator adds resident rehab options with recovery technology partnership … Diabetes drug metformin may greatly reduce severe COVID outcomes, clinical trial finds … Rosuvastatin linked...
Use of certain prescription meds linked to COVID-19 mortality
Jan 10, 2022
Discontinuation of ACE-I, ARB, metformin associated with elevated risk for death among hospitalized COVID-19 patients
After decade of progress, diabetes control loses steam as first-line therapies go underused
Jun 11, 2021
Reinvigorating the use of first-line therapies such as statins, metformin, ACE inhibitors or ARB is key to getting care and outcomes back on track, investigators say.
Metformin may prevent a common cause of vision loss in aging
Feb 01, 2021
The diabetes drug metformin may protect against age-related macular degeneration, a potentially blinding condition for which there appears to be no effective preventive measures, researchers contend.
Clinical briefs for Monday, Dec. 14
Dec 13, 2020
COVID-19 can induce seizures and movement disorders, even in moderate cases … CDC reports record flu vaccine distribution in a so-far mild season … FDA OKs first non-prescription, at-home COVID test...
Metformin may slow cognitive decline in people with diabetes
Sep 25, 2020
Researchers have found new potential for a safe and widely used medication. The discovery could be “life-changing” for patients at risk of dementia, they say.
Almost 60% of diabetic nursing home residents with chronic kidney disease are on a potentially problematic...
Mar 03, 2014
Nursing home residents who have diabetes and chronic kidney disease are commonly given medications that are not in keeping with best practice guidelines or prescribing information, according to recently...